- Home
- NSPR vs DMA Comparison
NSPR vs DMA Comparison
Compare NSPR & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- DMA
- Stock Information
- Founded
- NSPR 2005
- DMA 2011
- Country
- NSPR United States
- DMA United States
- Employees
- NSPR N/A
- DMA N/A
- Industry
- NSPR Medical/Dental Instruments
- DMA Trusts Except Educational Religious and Charitable
- Sector
- NSPR Health Care
- DMA Finance
- Exchange
- NSPR Nasdaq
- DMA Nasdaq
- Market Cap
- NSPR 75.1M
- DMA 77.5M
- IPO Year
- NSPR N/A
- DMA N/A
- Fundamental
- Price
- NSPR $2.44
- DMA $8.64
- Analyst Decision
- NSPR Strong Buy
- DMA
- Analyst Count
- NSPR 2
- DMA 0
- Target Price
- NSPR $4.50
- DMA N/A
- AVG Volume (30 Days)
- NSPR 386.2K
- DMA 34.6K
- Earning Date
- NSPR 08-05-2025
- DMA 01-01-0001
- Dividend Yield
- NSPR N/A
- DMA 2.04%
- EPS Growth
- NSPR N/A
- DMA N/A
- EPS
- NSPR N/A
- DMA N/A
- Revenue
- NSPR $7,027,000.00
- DMA N/A
- Revenue This Year
- NSPR $4.85
- DMA N/A
- Revenue Next Year
- NSPR $113.47
- DMA N/A
- P/E Ratio
- NSPR N/A
- DMA N/A
- Revenue Growth
- NSPR 8.49
- DMA N/A
- 52 Week Low
- NSPR $1.99
- DMA $4.78
- 52 Week High
- NSPR $3.80
- DMA $8.00
- Technical
- Relative Strength Index (RSI)
- NSPR 54.16
- DMA 46.28
- Support Level
- NSPR $2.12
- DMA $8.58
- Resistance Level
- NSPR $2.46
- DMA $8.77
- Average True Range (ATR)
- NSPR 0.16
- DMA 0.11
- MACD
- NSPR 0.01
- DMA -0.01
- Stochastic Oscillator
- NSPR 73.33
- DMA 25.09
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.